Unity Biotechnology issues voting preferred share to director to push dissolution; stock now OTC

Unity Biotechnology, Inc.

Issued one share of Series A Preferred to director/president Craig Jalbert for $1; share has 600M votes only on dissolution proposal.
Preferred share votes in same proportion as common stock votes on dissolution, neutralizing abstentions/non-votes.
Board approved dissolution on June 27, 2025; special stockholder meeting to seek approval.
Stock suspended from Nasdaq on July 9, 2025; now OTC under UNBX; Form 25 to delist.

item 1.01item 5.03item 3.02item 3.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.